S-23 is a selective androgen receptor modulator (SARM) developed by the pharmaceutical company GTX Inc. S-23 binds to the androgen receptor more effectively than older
LGD-4033 is arguably the most potent SARM currently available. It is currently being developed to improve recovery from hip fractures and combat sarcopenia in elderly
Cardarine, also known as GW-501516, is often labeled as a SARM (Selective Androgen Receptor Modulator) but in fact, it is a PPARδ (Peroxisome proliferator-activated receptor
Alkemya B.V. 24 – 28 Olympisch Stadion, Amsterdam, 1076 DE, the Netherlands
NL863052083B01
